Cloning and transfer of the Salmonella pathogenicity island 2 type III secretion system for studies of a range of gram-negative genera

Applied and Environmental Microbiology

Volumn 73, Issue 18, 2007, Pages 5911-5918

  Wilson, James W ^a,b   Coleman, Clint ^b   Nickerson, Cheryl A ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER THERAPIES; POTENTIAL BENEFITS; PROTEIN DELIVERY; SECRETION;

CELL GROWTH; CLONING; MACROPHAGES; ONCOLOGY; PROTEINS; TUMORS;

BACTERIA;

BACTERIAL PROTEIN; PROTEIN SSEB; UNCLASSIFIED DRUG; VACCINE;

BACTERIUM; CLONE; GENETIC ENGINEERING; PATHOGENICITY; SECRETION; VACCINE;

ALPHAPROTEOBACTERIA; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; EVOLUTION; GAMMAPROTEOBACTERIA; GENE CASSETTE; GENE EXPRESSION; GENE FUNCTION; GENETIC ENGINEERING; GRAM NEGATIVE BACTERIUM; MACROPHAGE; MOLECULAR CLONING; NONHUMAN; PATHOGENICITY ISLAND; PROTEIN SECRETION; SALMONELLA; SALMONELLA ENTERICA;

BACTERIAL PROTEINS; CLONING, MOLECULAR; GENOMIC ISLANDS; GRAM-NEGATIVE BACTERIA; PROTEIN ENGINEERING; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM;

ALPHAPROTEOBACTERIA; BACTERIA (MICROORGANISMS); GAMMAPROTEOBACTERIA; NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 34648816567     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.00952-07     Document Type: Article

References (43)

1. Angot, A., A. Vergunst, S. Genin, and N. Peeters. 2007. Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog. 3:e3.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1996. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, NY.
3. Baker, D., G. Church, J. Collins, D. Endy, J. Jacobson, J. Keasling, P. Modrich, C. Smolke, and R. Weiss. 2006. Engineering life: building a fab for biology. Sci. Am. 294:44-51.
4. Beuzon, C. R., G. Banks, J. Deiwick, M. Hensel, and D. W. Holden. 1999. pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium. Mol. Microbiol. 33:806-816.
5. Blattner, F. R., G. Plunkett III, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glasner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474.
6. Chen, L. M., G. Briones, R. O. Donis, and J. E. Galan. 2006. Optimization of the delivciy of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development. Infect. Immun. 74:5826-5833.
7. Cornelis, G. R. 2006. The type III secretion injectisome. Nat. Rev. Microbiol. 4:811-825.
8. Cornelis, G. R., and F. Van Gijsegem. 2000. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:735-774.
9. 2-terminal kinase pathway and increases human epithelial interleukin-8 production. Infect. Immun. 74:4104-4113.
10. Deiwick, J., T. Nikolaus, S. Erdogan, and M. Hensel. 1999. Environmental regulation of Salmonella pathogenicity island 2 gene expression. Mol. Microbiol. 31:1759-1773.
11. Deng, W., S. R. Liou, G. Plunkett III, G. F. Mayhew, D. J. Rose, V. Burland, V. Kodoyianni, D. C. Schwartz, and F. R. Blattner. 2003. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J. Bacteriol. 185:2330-2337.
12. Endy, D. 2005. Foundations for engineering biology. Nature 438:449-453.
13. Epaulard, O., B. Toussaint, L. Quenee, M. Derouazi, N. Bosco, C. Villiers, R. Le Berre, B. Guery, D. Filopon, L. Crombez, P. N. Marche, and B. Polack. 2006. Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector. Mol. Ther. 14:656-661.
14. Fu, P. 2006. A perspective of synthetic biology: assembling building blocks for novel functions. Biotechnol. J. 1:690-699.
15. Galan, J. E., and H. Wolf-Watz. 2006. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444:567-573.
16. Gulig, P. A., and R. Curtiss III. 1987. Plasmid-associated virulence of Salmonella typhimurium. Infect. Immun. 55:2891-2901.
17. Hansen-Wester, I., D. Chakravortty, and M. Hensel. 2004. Functional transfer of Salmonella pathogenicity island 2 to Salmonella bongori and Escherichia coli. Infect. Immun. 72:2879-2888.
18. Hensel, M., T. Nikolaus, and C. Egelseer. 1999. Molecular and functional analysis indicates a mosaic structure of Salmonella pathogenicity island 2. Mol. Microbiol. 31:489-498.
19. Hensel, M., J. E. Shea, S. R. Waterman, R. Mundy, T. Nikolaus, G. Banks, A. Vazquez-Torres, C. Gleeson, F. C. Fang, and D. W. Holden. 1998. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 30:163-174.
20. Hone, D. M., A. M. Harris, S. Chatfield, G. Dougan, and M. M. Levine. 1991. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9:810-816.
21. Husseiny, M. I., F. Wartha, and M. Hensel. 2007. Recombinant vaccines based on translocated effector proteins of Salmonella pathogenicity island 2. Vaccine 25:185-193.
22. Kuhle, V., and M. Hensel. 2002. SseF and SseG are translocated effectors of the type III secretion system of Salmonella pathogenicity island 2 that modulate aggregation of endosomal compartments. Cell. Microbiol. 4:813-824.
23. Lee, A. K., C. S. Detweiler, and S. Falkow. 2000. OmpR regulates the two-component system SsrA-SsrB in Salmonella pathogenicity island 2. J. Bacteriol. 182:771-781.
24. Lennox, E. S. 1955. Transduction of linked genetic characters of the host by bacteriophage Pl. Virology 1:190-206.
25. McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. Wilson. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.
26. Nickerson, C. A., and R. Curtiss III. 1997. Role of sigma factor RpoS in initial stages of Salmonella typhimurium infection. Infect. Immun. 65:1814-1823.
27. Nikolaus, T., J. Deiwick, C. Rappl, J. A. Freeman, W. Schroder, S. I. Miller, and M. Hensel. 2001. SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon. J. Bacteriol. 183:6036-6045.
28. Nishikawa, H., E. Sato, G. Briones, L. M. Chen, M. Matsuo, Y. Nagata, G. Ritter, E. Jager, H. Nomura, S. Kondo, I. Tawara, T. Kato, H. Shiku, L. J. Old, J. E. Galan, and S. Gnjatic. 2006. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J. Clin. Investig. 116:1946-1954.
29. Ochman, H., F. C. Soncini, F. Solomon, and E. A. Groisman. 1996. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc. Natl. Acad. Sci. USA 93:7800-7804.
30. Pansegrau, W., E. Lanka, P. T. Barth, D. H. Figurski, D. G. Guiney, D. Haas, D. R. Helinski, H. Schwab, V. A. Stanisich, and C. M. Thomas. 1994. Complete nucleotide sequence of Birmingham IncP alpha plasmids. Compilation and comparative analysis. J. Mol. Biol. 239:623-663.
31. Panthel, K., K. M. Meinel, V. E. Sevil Domenech, G. Geginat, K. Linkemann, D. H. Busch, and H. Russmann. 2006. Prophylactic anti-tumor immunity against a murine fibrosarcoma triggered by the Salmonella type III secretion system. Microbes Infect. 8:2539-2546.
32. Patel, J. C., and J. E. Galan. 2006. Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J. Cell Biol. 175:453-463.
33. Patel, J. C., and J. E. Galan. 2005. Manipulation of the host actin cytoskeleton by Salmonella - all in the name of entry. Curr. Opin. Microbiol. 8:10-15.
34. Porwollik, S., R. M. Wong, and M. McClelland. 2002. Evolutionary genomics of Salmonella: gene acquisitions revealed by microarray analysis. Proc. Natl. Acad. Sci. USA 99:8956-8961.
35. Russmann, H. 2003. Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella. Int. J. Med. Microbiol. 293:107-112.
36. Russmann, H. 2004. Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease. Int. J. Med. Microbiol. 293:565-569.
37. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Press, Plainview, NY.
38. Schlumberger, M. C., A. J. Muller, K. Ehrbar, B. Winnen, I. Duss, B. Stecher, and W. D. Hardt. 2005. Real-time imaging of type III secretion: Salmonella SipA injection into host cells. Proc. Natl. Acad. Sci. USA 102: 12548-12553.
39. Uchiya, K., M. A. Barbieri, K. Funato, A. H. Shah, P. D. Stahl, and E. A. Groisman. 1999. A Salmonella virulence protein that inhibits cellular trafficking. EMBO J. 18:3924-3933.
40. Wilson, J. W., D. H. Figurski, and C. A. Nickerson. 2004. VEX-capture: a new technique that allows in vivo excision, cloning, and broad-host-range transfer of large bacterial genomic DNA segments. J. Microbiol. Methods 57:297-308.
41. Wilson, J. W., and C. A. Nickerson. 2006. Cloning of a functional Salmonella SPI-1 type III secretion system and development of a method to create mutations and epitope fusions in the cloned genes. J. Biotechnol. 122:147-160.
42. Wilson, J. W., and C. A. Nickerson. 2006. A new experimental approach for studying bacterial genomic island evolution identifies island genes with bacterial host-specific expression patterns. BMC Evol. Biol. 6:2.
43. Wilson, J. W., E. A. Sia, and D. H. Figurski. 1997. The kilE locus of promiscuous IncP alpha plasmid RK2 is required for stable maintenance in Pseudomonas aeruginosa. J. Bacteriol. 179:2339- 2347.